Cancer Patients Flashcards

1
Q

Limitations with Pain Detection in Cancer Patients

A

Majority of conventional pain scales validated in context of acute, postoperative pain or chronic OA pain
o Suitability for cancer pain assessment might be limited

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Frequency of Pain In Cancer Patients

A

Pain = common aliment inhuman cancer patients, incidence of cancer related pain at initial dx ~ 30%
o Upon disease progression up to 60 to 85% human cancer patients experience pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Visual Analog Scale

A

Horizontal line generally measuring 100mm in length

Vertical mark placed anywhere between 0 (no pain) and 100 (worst possible pain)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Numerical Rating Scale

A

 Evaluator chooses a number often btw 0-5
 Other numbers both higher and lower used
 0 represents no pain, highest number on scale = worst pain imaginable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Causes of Cancer Pain

A
  1. Direct invasion of tumor cells into nerves, bones, soft tissue, ligaments, fascia
  2. Distension, obstruction of internal organs secondary to tumor infiltration
  3. Erosive or inflammatory processes elicited by cancel cells within microenvironment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

WHO Analgesic Ladder - Step 1

A

Mild to moderate pain
Non opioid +/- adjuvant analgesics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

WHO Analgesic ladder - Step 2

A

Moderate to Severe Pain

Weak opioids
+/- non-opioids
+/- adjuvant analgesics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

WHO Analgesic Ladder - Step 3

A

Severe Pain

Strong Opioids
+/- Non-opioids
+/- adjuvant analgesics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Nociceptive Pain

A

Direct tissue injury from tumor infiltration,

Peritumoral inflammation –> stimulation of peripheral pain R in cutaneous, deeper MSK structure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Somatic pain

A

Direct injury DT cancer cell invasion into skeleton, soft tissues, tendons, ligaments

In people, described as focal and stabbing in nature

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Visceral Pain

A

Arises from cancer cell infiltration, compression, distortion of internal organs within abdominal, thoracic, pelvic cavities

In people, described as diffuse and squeezing in character

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Neuropathic Pain

A

Directly related to cancer cell infiltration of peripheral N, nerve plexi, roots, SC

In people, described as burning, shooting, pins/needles, or numbness in nature

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Bone

A

living organ, rich in blood supply, nerves

Fxn: bearing weight, withstanding cyclic compressive forces

Compromise in structural integrity (quantity, quality) = risk for pain, pathologic fx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Dogs and Bone Tumors

A

osteosarcoma (OSA) –> focal skeletal pain, can also see with metastatic carcinoma, multiple myeloma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cats and Bone Tumors

A

primary bone tumors occur less frequently than dogs, bone involvement secondary to invasion by oral SCC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Development of Bone Pain

A

Skeletal bone: mosaic of afferent nociceptors, most closely concentrated within periosteum, intramedullary cavity
 To a lesser extent within mineralized bone matrix

Progressive intramedullary tumor cell growth + consequent chronic afferent nociceptor stimulation  neurochemical characteristics of chronic bone pain detected in both peripheral, central compartments
–Peripheral = afferent nociceptors, DRG
–Central: DH of SC

17
Q

Main Mechanisms of Bone Cancer Pain

A
  1. Presence of cancer cells –> release of chemical mediators by neoplastic, non-neoplastic stromal cells –> stimulate sensory afferent nociceptors –> painful sensations
  2. Generation, maintenance of bone cancer pain directly attributed to pathologic osteoclastic bone resorption
    –Acid-sensing channels
  3. Bone erosion, subsequent mechanical instability
     Allows for distortion of punitive mechanotransducers belonging to TRPV R family –> innervate bone
18
Q

How do viable cancer cells directly promote generation of bone pain?

A

 Secretion of nociceptor activating ligands
 Attraction of trafficking immune cells
 Subversion of osteoclastic activities

19
Q

Osteoclasts

A

 Monocyte-macrophage cell lineage
 Characterized by high expressions of tartrate-resistant acid phosphatase, cathepsin K
 Homeostatic conditions: resorb bone in balance with new bone formation by osteoblasts

20
Q

How do bone cancers hijack osteoclastic activity?

A

 Bone cancers of either primary (sarcoma) or metastatic origin (carcin thisoma) dysregulate osteoclastic activities via R activation of nuclear factor kappa-B

21
Q

Aminobisphosphonates

A

induce osteoclast apoptosis via inhibition of mevalonate pathway
 First line agents for management of malignant skeletal events, bone cancer patients, good for bone pain

22
Q

What form of radiation is the most effective tx for reducing bone pain?

A

Ionizing radiation